newsfilter
← Latest News
GlobeNewswire·

Genocea Biosciences Provides Clinical Update

CAMBRIDGE, Mass., July 20, 2020 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today announced...